title: Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes.
abstract: OBJECTIVE
  To determine the clinical efficacy of a 2-year continuous sub-antimicrobial dose doxycycline (SDD; 20 mg bid) in post-menopausal, osteopenic, oestrogen-deficient women on periodontal maintenance.
  
  
  METHODS
  One-hundred and twenty-eight subjects were randomized to SDD (n=64) or placebo (n=64). Clinical measurements were performed at posterior interproximal sites at baseline and every 6 months during this 2-year randomized, double-blind, placebo-controlled clinical trial with adjunctive, no-cost 3-4-month periodontal maintenance. Statistical analyses of secondary outcomes from this clinical trial used Generalized Estimating Equations in primarily intent-to-treat analyses.
  
  
  RESULTS
  For the placebo group, 3.4% of the sites showed improvement in clinical attachment levels (CAL) and 2.7% had progressive loss in CAL; for the SDD group, 5.0% of the sites showed an improvement in CAL and 2.2% had progressive loss in CAL. This difference (2.1% of sites) was more favourable in the SDD group than in the placebo [odds ratio (OR)=0.81 [corrected] 95% confidence interval (CI): 0.67-0.97, p=0.03] in these well-maintained patients, whereas probing depths, bleeding on probing and supragingival plaque did not differ significantly between groups (p>0.2). However, in exploratory subgroup analysis of non-smokers, SDD showed reduced bleeding versus placebo (27%versus 33%; p=0.05). In protocol-adherent subjects, the odds of bleeding were 34% lower for SDD (p=0.05).
  
  
  CONCLUSIONS
  Analyses of secondary outcomes of this clinical trial indicated that SDD may be of benefit in reducing progressive attachment loss in post-menopausal females; additional research is needed to confirm these findings. Protocol registered at (ClinicalTrials.gov). Identifier:NCT00066027.
authors: Department of Surgical Specialties, University of Nebraska Medical Center College of Dentistry, Lincoln, NE 68583-0740, USA. rareinha@unmc.edu
authors: Richard A
authors: RA
authors: Reinhardt
authors: Julie A
authors: JA
authors: Stoner
authors: Lorne M
authors: LM
authors: Golub
authors: Mark S
authors: MS
authors: Wolff
authors: Hsi-Ming
authors: HM
authors: Lee
authors: His-Ming
authors: HM
authors: Lee
authors: Trudy A
authors: TA
authors: Meinberg
authors: James C
authors: JC
authors: Lynch
authors: Maria E
authors: ME
authors: Ryan
authors: Timo
authors: T
authors: Sorsa
authors: Jeffrey B
authors: JB
authors: Payne
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001851:Bone Diseases, Metabolic / Q000150:complications; D003773:Dental Plaque / Q000517:prevention & control; D004311:Double-Blind Method; D004318:Doxycycline / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D005884:Gingival Hemorrhage / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications; D017622:Periodontal Attachment Loss / Q000517:prevention & control; D010510:Periodontal Diseases / Q000517:prevention & control*; D010514:Periodontal Pocket / Q000517:prevention & control; D010518:Periodontitis / Q000517:prevention & control; D010919:Placebos; D017698:Postmenopause; D012907:Smoking; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D010919:Placebos; D004318:Doxycycline
references: J Periodontol. 2000 Apr;71(4):521-32
references: 10807113
references: Calcif Tissue Int. 2005 Jul;77(1):9-14
references: 16007480
references: Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2544-57
references: 10937565
references: J Clin Periodontol. 2000 Sep;27(9):658-64
references: 10983599
references: J Periodontol. 2000 Sep;71(9):1492-8
references: 11022780
references: J Rheumatol. 2001 Feb;28(2):336-40
references: 11246672
references: J Clin Periodontol. 2001 Aug;28(8):782-9
references: 11442739
references: J Periodontol. 2002 Apr;73(4):460-70
references: 11990448
references: J Periodontol. 2002 Jul;73(7):762-9
references: 12146536
references: Biochem Pharmacol. 2003 Nov 1;66(9):1809-19
references: 14563491
references: Ann Periodontol. 2003 Dec;8(1):12-37
references: 14971246
references: J Periodontol. 2004 Jan;75(1):16-22
references: 15025212
references: J Clin Periodontol. 2004 Aug;31(8):680-4
references: 15257747
references: J Periodontol. 2004 Aug;75(8):1068-76
references: 15455733
references: J Periodontol. 1989 Sep;60(9):485-90
references: 2677301
references: J Clin Periodontol. 1994 Feb;21(2):91-7
references: 8144739
references: Osteoporos Int. 1994 Mar;4(2):104-9
references: 8003839
references: J Periodontol. 1994 Dec;65(12):1134-8
references: 7877085
references: J Periodontol. 1996 Feb;67(2):103-8
references: 8667129
references: Control Clin Trials. 1997 Dec;18(6):530-45; discussion 546-9
references: 9408716
references: Adv Dent Res. 1998 Nov;12(2):12-26
references: 9972117
references: J Clin Periodontol. 1999 Jun;26(6):374-80
references: 10382577
references: Ann N Y Acad Sci. 1999 Jun 30;878:335-46
references: 10415739
references: J Periodontol. 1999 Aug;70(8):823-8
references: 10476887
references: J Periodontol. 1999 Sep;70(9):982-91
references: 10505800
references: Int J Periodontics Restorative Dent. 2004 Dec;24(6):528-43
references: 15626316
references: J Periodontol. 2004 Nov;75(11):1500-8
references: 15633327
references: Gerodontology. 2005 Mar;22(1):37-43
references: 15747897
references: J Clin Periodontol. 2005 Mar;32(3):244-53
references: 15766366